Match!
Journal of Cardiac Failure
IF
3.86
Papers
14037
Papers 13871
1 page of 1,388 pages (13.9k results)
Newest
#1Sarah Yu (Columbia University)
#2Marisa Cevasco (Columbia University)
Last.Koji Takeda (Columbia University)H-Index: 14
view all 13 authors...
Abstract Background Left ventricular assist device (LVAD) therapy has revolutionized the treatment options for advanced heart failure patients. Patient selection is essential in obtaining successful results. However, little data exists on the outcomes of patients evaluated for LVAD therapy but subsequently rejected or deferred. Methods This is a retrospective review of all patients referred for LVAD therapy at our institution between January 2009 to December 2016. Baseline demographics and INTER...
Source
#1Dominic A.M.J. Theuns (EUR: Erasmus University Rotterdam)H-Index: 31
#2Nick van Boven (EUR: Erasmus University Rotterdam)H-Index: 4
Last.Felix Zijlstra (EUR: Erasmus University Rotterdam)H-Index: 41
view all 10 authors...
Abstract Background – The beneficial effects of a cardiac resynchronization defibrillator (CRT-D) in patients with heart failure, low LVEF, and wide QRS have clearly been established. Nevertheless, mortality remains high in some patients. The aim of this study was to develop and validate a risk score to identify patients at high risk for early mortality who are implanted with a CRT-D. Methods and Results – For predictive modelling, 1282 consecutive patients from 5 centers (74% male; median age 6...
Source
#1Teruhiko Imamura (U of C: University of Chicago)H-Index: 4
#2Gene Kim (U of C: University of Chicago)H-Index: 29
Last.Nir Uriel (U of C: University of Chicago)H-Index: 33
view all 17 authors...
ABSTRACT Aim Hemocompatibility-related adverse events (HRAE) are a major cause of readmissions in patients with left ventricular assist device (LVAD). The impact of aortic insufficiency (AI) on HRAE remains uncertain. We aimed to investigate the impact of AI on HRAE. Methods and Results Patients who underwent LVAD implantation between August 2014 and July 2017 and had echocardiograms 3 months post-LVAD were enrolled. AI severity was assessed by measuring the systolic/diastolic ratio of flow and ...
Source
#1Alessandro Di Toro (FUI: Foundation University, Islamabad)H-Index: 2
#2Lorenzo Giuliani (FUI: Foundation University, Islamabad)H-Index: 3
Last.Eloisa Arbustini (FUI: Foundation University, Islamabad)H-Index: 6
view all 4 authors...
Source
#1Teruhiko Imamura (U of C: University of Chicago)H-Index: 4
#2Nikhil Narang (U of C: University of Chicago)H-Index: 7
Source
#1Todd Dardas (UW: University of Washington)H-Index: 10
Source
#1Isac C. Thomas (UCSD: University of California, San Diego)H-Index: 5
#2Marin Nishimura (UCSD: University of California, San Diego)H-Index: 4
Last.Barry H. Greenberg (UCSD: University of California, San Diego)H-Index: 73
view all 9 authors...
Abstract Background Despite a global epidemic of methamphetamine abuse, methamphetamine-associated heart failure (MethHF) remains poorly understood. We sought to evaluate characteristics and outcomes for patients with MethHF. Methods We reviewed the electronic health records of the University of California, San Diego from 2005-16. We compared characteristics and outcomes between 896 patients with MethHF and 20,576 patients with heart failure (HF) identified using diagnosis codes, urine toxicolog...
Source
#1Jozine M. ter Maaten (UMCG: University Medical Center Groningen)H-Index: 15
#2Pieter Martens (University of Hasselt)H-Index: 10
Last.Wilfried Mullens (University of Hasselt)H-Index: 19
view all 7 authors...
Abstract Introduction Limited data is available on the effect of severe chronic kidney disease (CKD) on the response to cardiac resynchronization therapy (CRT) as these patients are often excluded from trials. We therefore aimed to assess the effect of CRT on renal function, reverse remodeling and outcome across all stages of CKD in a large patient population of CRT recipients. Methods 798 consecutive heart failure (HF) patients undergoing CRT implantation between October 2008 and September 2016...
Source
#1Taylor S. Howard (BCM: Baylor College of Medicine)
#2Santiago O. Valdes (BCM: Baylor College of Medicine)H-Index: 7
Last.Jeffrey J. Kim (BCM: Baylor College of Medicine)H-Index: 20
view all 11 authors...
Abstract Background: Wolff-Parkinson-White (WPW) has been associated with left ventricular noncompaction (LVNC) in children. Little is known about the prevalence of this association, clinical outcomes, and treatment options. Methods: Retrospective review of subjects with LVNC. LVNC was defined by established criteria; those with congenital heart disease were excluded. Electrocardiograms were reviewed for presence of preexcitation. Outcomes were compared between those with isolated LVNC and those...
Source
#1Yogesh N.V. Reddy (Mayo Clinic)H-Index: 19
#2Masaru Obokata (Mayo Clinic)H-Index: 12
Last.Barry A. Borlaug (Mayo Clinic)H-Index: 56
view all 14 authors...
Abstract Background Patients with heart failure (HF) with preserved ejection fraction (HFpEF) and obesity display a number of pathophysiologic features that may render them more or less vulnerable to negative effects of decongestion on renal function, including greater right ventricular remodeling, plasma volume expansion, and pericardial restraint. We aimed to contrast the renal response to decongestion in obese compared to non-obese HFpEF Methods and Results NIH heart failure network studies t...
Source
12345678910
Top fields of study
Cardiology
Heart failure
Diabetes mellitus
Medicine
Ejection fraction